Covid-19 coronavirus: contracts and supply chains
Read our latest insights on the impact of Covid-19 on issues ranging from force majeure and MAC clauses in contracts to understanding the most significant M&A and antitrust risks that organisations need to manage.
Global
- Webinar: Beyond Covid-19: Implications for intellectual property
- Covid-19 coronavirus: How the global life sciences sector is responding to the pandemic
- Covid-19 coronavirus: Implications of current travel restrictions for the tax residency status of companies
- Contracts and Covid-19: what to do if you or your counterparty cannot perform
- Covid-19 coronavirus: global survey of moratoria and forbearance measures
- Covid-19 coronavirus: points to consider on M&A transactions
- Covid-19 coronavirus: global merger review update
- Covid-19 coronavirus update: global application of antitrust rules
- Covid-19 coronavirus: key legal considerations for bancassurance arrangements
- Covid-19 coronavirus: multi-jurisdictional survey on force majeure and equivalent doctrines
- Webinar: The key impacts of Covid-19 coronavirus on Intellectual Property
Belgium
China
France
Italy
Luxembourg
- Covid-19 coronavirus: key considerations from a Luxembourg corporate law perspective
- Covid-19 coronavirus: key considerations from a Luxembourg real estate perspective
- Covid-19 coronavirus: hot topics from a Luxembourg law perspective
Netherlands
- Keep up with our latest Covid-19 insights on the Allen & Overy Amsterdam blog (opens in new window)